Skip to main content
Top
Published in: Journal of Cancer Survivorship 6/2017

01-12-2017 | Editorial

Introduction to special section on digital technology and cancer survivorship

Authors: Kate Absolom, Patricia Holch, Ziv Amir

Published in: Journal of Cancer Survivorship | Issue 6/2017

Login to get access

Excerpt

Technological advances in health care have led to increasing numbers of curable and treatable cancers extending the lives of many people around the world. Alongside these advances, the development and accessibility of modern technology including the internet, social media, smart phones and apps are revolutionising how we communicate and receive information and store and monitor data. This in turn has led to novel methods of supporting people living with and beyond cancer. In this special section of the Journal of Cancer Survivorship, we are pleased to present a collection of seven papers showcasing a variety of technologies and research methodologies. Each demonstrates the utilisation of different digital approaches for either improving our understanding of the lives of people surviving cancer or assisting the management of the consequences of the disease. Collectively, the papers raise a number of important questions for future exploration as we adapt to an ever more digitally focussed society. …
Literature
2.
go back to reference Abrol E, Groszmann M, Pitman A, Hough R, Taylor RM, Aref-Adib G. Exploring the digital technology preferences of teenagers and young adults (TYA) with cancer and survivors: a cross-sectional service evaluation questionnaire. J Cancer Surviv. 2017. https://doi.org/10.1007/s11764-017-0618-z. Abrol E, Groszmann M, Pitman A, Hough R, Taylor RM, Aref-Adib G. Exploring the digital technology preferences of teenagers and young adults (TYA) with cancer and survivors: a cross-sectional service evaluation questionnaire. J Cancer Surviv. 2017. https://​doi.​org/​10.​1007/​s11764-017-0618-z.
3.
go back to reference McNeill NA, Kors WA, Bosscha MI, van Dijk J, Fabius AWM, Ton Houffelaar T, Verdonck-de Leeuw IM, Moll MC. Feasibility of RetinoQuest: e-health application to facilitate and improve additional care for retinoblastoma survivors. J Cancer Surviv. 2017. https://doi.org/10.1007/s11764-017-0642-z. McNeill NA, Kors WA, Bosscha MI, van Dijk J, Fabius AWM, Ton Houffelaar T, Verdonck-de Leeuw IM, Moll MC. Feasibility of RetinoQuest: e-health application to facilitate and improve additional care for retinoblastoma survivors. J Cancer Surviv. 2017. https://​doi.​org/​10.​1007/​s11764-017-0642-z.
4.
go back to reference Willems RA, Mesters I, Lechner L, Kanera IM, Bolman CAW. Long-term effectiveness and moderators of a web-based tailored intervention for cancer survivors on social and emotional functioning, depression, and fatigue: randomized controlled trial. J Cancer Surviv. 2017. https://doi.org/10.1007/s11764-017-0625-0. Willems RA, Mesters I, Lechner L, Kanera IM, Bolman CAW. Long-term effectiveness and moderators of a web-based tailored intervention for cancer survivors on social and emotional functioning, depression, and fatigue: randomized controlled trial. J Cancer Surviv. 2017. https://​doi.​org/​10.​1007/​s11764-017-0625-0.
6.
go back to reference Timmerman JG, Dekker-van Weering MG, Stuiver MM, Groen WG, Wouters MW, Tonis TM, et al. Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors: actual use and feasibility in clinical practice. J Cancer Surviv. 2017. https://doi.org/10.1007/s11764-017-0611-6. Timmerman JG, Dekker-van Weering MG, Stuiver MM, Groen WG, Wouters MW, Tonis TM, et al. Ambulant monitoring and web-accessible home-based exercise program during outpatient follow-up for resected lung cancer survivors: actual use and feasibility in clinical practice. J Cancer Surviv. 2017. https://​doi.​org/​10.​1007/​s11764-017-0611-6.
Metadata
Title
Introduction to special section on digital technology and cancer survivorship
Authors
Kate Absolom
Patricia Holch
Ziv Amir
Publication date
01-12-2017
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 6/2017
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-017-0644-x

Other articles of this Issue 6/2017

Journal of Cancer Survivorship 6/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine